204 related articles for article (PubMed ID: 24721120)
21. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy.
Ornoy A
Reprod Toxicol; 2007 Jul; 24(1):31-41. PubMed ID: 17548185
[TBL] [Abstract][Full Text] [Related]
22. Localized fetomaternal hyperglycemia: spatial and kinetic definition by positron emission tomography.
Yao J; Wang C; Walsh SA; Hu S; Sawatzke AB; Dang D; Segar JL; Ponto LL; Sunderland JJ; Norris AW
PLoS One; 2010 Aug; 5(8):e12027. PubMed ID: 20700464
[TBL] [Abstract][Full Text] [Related]
23. Yolk sac failure in embryopathy due to hyperglycemia: ultrastructural analysis of yolk sac differentiation associated with embryopathy in rat conceptuses under hyperglycemic conditions.
Pinter E; Reece EA; Leranth CZ; Sanyal MK; Hobbins JC; Mahoney MJ; Naftolin F
Teratology; 1986 Feb; 33(1):73-84. PubMed ID: 3738811
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress-induced miR-27a targets the redox gene nuclear factor erythroid 2-related factor 2 in diabetic embryopathy.
Zhao Y; Dong D; Reece EA; Wang AR; Yang P
Am J Obstet Gynecol; 2018 Jan; 218(1):136.e1-136.e10. PubMed ID: 29100869
[TBL] [Abstract][Full Text] [Related]
25. Immunostimulation by complete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, or interferon-gamma reduces severity of diabetic embryopathy in ICR mice.
Punareewattana K; Holladay SD
Birth Defects Res A Clin Mol Teratol; 2004 Jan; 70(1):20-7. PubMed ID: 14745891
[TBL] [Abstract][Full Text] [Related]
26. Genetic and environmental influence on diabetic rat embryopathy.
Ejdesjö A; Wentzel P; Eriksson UJ
Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E454-67. PubMed ID: 21119026
[TBL] [Abstract][Full Text] [Related]
27. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment.
Wentzel P; Welsh N; Eriksson UJ
Diabetes; 1999 Apr; 48(4):813-20. PubMed ID: 10102698
[TBL] [Abstract][Full Text] [Related]
28. Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis.
Sivan E; Reece EA; Wu YK; Homko CJ; Polansky M; Borenstein M
Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):793-9. PubMed ID: 8885724
[TBL] [Abstract][Full Text] [Related]
29. Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos.
Gäreskog M; Cederberg J; Eriksson UJ; Wentzel P
Reprod Toxicol; 2007 Jan; 23(1):63-74. PubMed ID: 17034987
[TBL] [Abstract][Full Text] [Related]
30. Renal development in high-glucose ambience and diabetic embryopathy.
Chugh SS; Wallner EI; Kanwar YS
Semin Nephrol; 2003 Nov; 23(6):583-92. PubMed ID: 14631566
[TBL] [Abstract][Full Text] [Related]
31. Impact of hyperglycemia on early embryo development and embryopathy: in vitro experiments using a mouse model.
Fraser RB; Waite SL; Wood KA; Martin KL
Hum Reprod; 2007 Dec; 22(12):3059-68. PubMed ID: 17933753
[TBL] [Abstract][Full Text] [Related]
32. Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos.
Wentzel P; Ejdesjö A; Eriksson UJ
Diabetes; 2003 May; 52(5):1222-8. PubMed ID: 12716756
[TBL] [Abstract][Full Text] [Related]
33. [Differentially expressed genes in diabetes-induced embryopathy].
Ma XD; Ma X; Wu XM; Chen BL; Wang DT
Yi Chuan; 2009 Mar; 31(3):280-4. PubMed ID: 19273441
[TBL] [Abstract][Full Text] [Related]
34. Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats.
Reece EA; Wu YK; Zhao Z; Dhanasekaran D
Am J Obstet Gynecol; 2006 Feb; 194(2):580-5. PubMed ID: 16458664
[TBL] [Abstract][Full Text] [Related]
35. Pregestational Obesity-Induced Embryopathy.
Suárez-Román G; Fernández-Romero T; Perera-Calderín AJ; Rodríguez-Sosa VM; Arranz C; Hernández SC
Reprod Sci; 2016 Sep; 23(9):1250-7. PubMed ID: 27089913
[TBL] [Abstract][Full Text] [Related]
36. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress.
Li R; Chase M; Jung SK; Smith PJ; Loeken MR
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E591-9. PubMed ID: 15928021
[TBL] [Abstract][Full Text] [Related]
37. PPARdelta and its activator PGI2 are reduced in diabetic embryopathy: involvement of PPARdelta activation in lipid metabolic and signalling pathways in rat embryo early organogenesis.
Higa R; González E; Pustovrh MC; White V; Capobianco E; Martínez N; Jawerbaum A
Mol Hum Reprod; 2007 Feb; 13(2):103-10. PubMed ID: 17148578
[TBL] [Abstract][Full Text] [Related]
38. Genotoxicity and diabetic embryopathy: impaired expression of developmental control genes as a cause of defective morphogenesis.
Chang TI; Loeken MR
Semin Reprod Endocrinol; 1999; 17(2):153-65. PubMed ID: 10528366
[TBL] [Abstract][Full Text] [Related]
39. Hyperglycaemia potentiates the teratogenicity of retinoic acid in diabetic pregnancy in mice.
Leung MBW; Choy KW; Copp AJ; Pang CP; Shum ASW
Diabetologia; 2004 Mar; 47(3):515-522. PubMed ID: 14966672
[TBL] [Abstract][Full Text] [Related]
40. Teratogenicity of 3-deoxyglucosone and diabetic embryopathy.
Eriksson UJ; Wentzel P; Minhas HS; Thornalley PJ
Diabetes; 1998 Dec; 47(12):1960-6. PubMed ID: 9836531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
